1.Supravalvular aortic stenosis: report of 3 cases.
Ye Jee JUN ; Shin Yeoung LEE ; Sang Joon OH ; Chang Ho KIM
The Korean Journal of Thoracic and Cardiovascular Surgery 1991;24(3):280-286
No abstract available.
Aortic Stenosis, Supravalvular*
2.Epithelial ovarian cancer:comparison of serous and mucinous cystadenocarcinoma.
Dae Woon KIM ; Ki Hun LEE ; Jung Hwan SHIN ; Kyung Tai KIM ; Youn Yeoung HWANG ; Hyung MOON ; Jai Auk LEE
Korean Journal of Obstetrics and Gynecology 1993;36(7):2706-2714
No abstract available.
Cystadenocarcinoma, Mucinous*
;
Mucins*
3.Detection of the c-m c Oncogene Amplification in Ovarian Carcinomas by Differential Polymerase Chain Reaction.
Geun Shin LYU ; Chan Kum PARK ; Chun Geun LEE ; Youl Hee CHO ; Youn Yeoung HWANG ; Jung Dal LEE
Korean Journal of Pathology 1997;31(7):644-654
The amplification of c-myc oncogene was evaluated in 42 cases of ovarian carcinomas to correlate with clinical parameters. Using oligonucleotide primers, sequences from the c-myc exon-3 gene and from a control gene, tissue plasminogen activator (tPA), were amplified simultaneously by polymerase chain reaction (PCR). After the products of differential PCR (d-PCR) were electrophoresed, slot blot hybridization was performed, and hybridized with P32 dATP-labeled myc and tPA oligonucleotide probes and then autoradiographed. The signal intensities of the two products were quantitated by densitometry and the ratios of two products (c-myc/tPA) were measured. The ovarian carcinomas showed significantly increased amplification of c-myc oncogene Oligonucleoti compared to normal control group (p<0.05). 15 of 42 cases (35.7%) showed various degrees of the MYC gene amplification up to 27 folds in various histologic types of ovarian carcinomas. No significant differences of the MYC gene amplification according to histologic subtypes, tumor action) grades and clinical stages of ovarian carcinomas were present.
Densitometry
;
DNA Primers
;
Genes, myc
;
Oligonucleotide Probes
;
Oncogenes*
;
Polymerase Chain Reaction*
;
Tissue Plasminogen Activator
4.A Case of Primary Adenocarcinoma of the Fallopian Tube.
Ki Heon LEE ; Sung Soo SHIN ; Ju Hyun YOO ; Jung Bae YOO ; Kyung Tai KIM ; Youn Yeoung HWANG ; Jai Auk LEE
Korean Journal of Gynecologic Oncology and Colposcopy 1993;4(2):88-95
Primary adenocarcinoma of the fallopian tube is an extremely rare malignancy of the female genital tract. We had experienced a case of primary adenocarcinoma of the left fallopian tube which diagnosed ineidentally on the basis of the biopsy findings, and reported the case with a brief review of the concerned literatures.
Adenocarcinoma*
;
Biopsy
;
Fallopian Tubes*
;
Female
;
Humans
5.Clinical observation of aortic dissection.
Byeong Ik JANG ; Jin Ho PARK ; Dong Ku SHIN ; Yeoung Jo KIM ; Bong Sup SHIM ; Hyun Woo LEE ; Su Hyen KIM ; Sung Sae HAN
Yeungnam University Journal of Medicine 1992;9(2):334-341
A clinical review of 34 cases of aortic dissection which were admitted to Yeungnam University hospital between March 1983 and April 1992. The results are as follows: 1. The peak incidence was in 5th, 6th decade and male to female ratio was 1.83:1. 2. The most common cause of aortic dissection was atherosclerosis and hypertension (79%). 3. The most common presenting symptom was pain (73%). but dyspnea, palpable mass, murmur, shock were also observed. 4. Abnormal electrocardiographic finding was myocardial ischemia in 6 cases, arrhythmia in 5 cases, LVH in 5 cases. 5. The X-ray findings showed abnormal aortic contour in 10 cases but normal X-ray finding was observed in 63% of DeBaKey Type III. 6. The most common diagnostic procedure was echocardiogram and abdominal Ultrasonography. 7. The mortality of all cases was 20%, operation mortality was 18% but no death of medically treatment in medical indication.
Arrhythmias, Cardiac
;
Atherosclerosis
;
Dyspnea
;
Electrocardiography
;
Female
;
Humans
;
Hypertension
;
Incidence
;
Male
;
Mortality
;
Myocardial Ischemia
;
Shock
;
Ultrasonography
6.Predictability of the Survival using Prognostic Index (PI) of Patients with Epithelial Ovarian Cancer.
Sam Hyun CHO ; Seung Ryong KIM ; Hyang MOON ; Jai Auk LEE ; Youn Yeoung HWANG ; Young Jin MOON ; Joong Sik SHIN ; Kyung Tal KIM ; Chang Young CHUNG
Korean Journal of Gynecologic Oncology and Colposcopy 1999;10(2):173-182
OBJECTIVES: To predict of the survival of patients with epithelial ovarian cancer, multivariable analysis was done to identify variables with independent prognostic factors. Based on materials from 191 clinical trials performed by Department of Obstetrics and Gynecology, Hanyang University Hospital, we constructed a prognostic index (Pp with considerable predictive power for long-term survival of patients with epithelial ovatian cancer treated with cis-platin based combination chemotherapy, METHODS: On identifying variables with independent prognostic value, statistical analysis were performed with clinicopathologic variables including age, FIGO stage, histologic subtype, histologic grade, residual tumor, presence of ascites, pretreatment levels of hemoglobin, platelet, and tumor markers(CA 125, CA 19-9). We also analyzed biological variables using immunohistochemical staining for GST-pie (glutathione-s-transferase-pie), p-glycoprotein, and MT (metallothinein) as a drug resistance and uPA (urokinase type plasminogen activator), PAI-1 (plasminogen activator inhibitor-l), nm23 (nonmetastatic gene 23) as a tumor invasion and metastasis. In addition, univariable analysis was performed followed by multivariable analysis using Coxs proportional hazards model to identify variables predictive of poor prognosis. Prognostic index (PI) was calculated based on sum of individual beta-coefficient of the most important independent prognostic value. RESULTS: With univariable analysis, age, FIGO stage, histologic grade, histologic subtype, presence of ascites, residual tumor, initial value of CA 125, MT, uPA, and PAI-1 were found to predict of patients survival. In the multivariable analysis and proportional hazard model, the pretreatment characteristics needed for the calculation of the PI are the age, the site of metastases expressed as stage, the histologic subtype, the size of residual tumor, the histological grade, and the presence of ascites. In the subgroup comprising the 10% of the patients with the best prognosis, 5-year survival rate was 78.9%, whereas in the subgmup comprising the 10% with the poorest prognosis, 5-year survival rate was 7.1%, which illustrates the large variability of the prognosis among patients. CONCLUSIONS: The PI was found to retain its value after response was achieved. The information provided by the PI can be expected to be useful in treatment planning and the proper stratification of patients in clinical trials.
Ascites
;
Blood Platelets
;
Drug Resistance
;
Drug Therapy, Combination
;
Gynecology
;
Humans
;
Neoplasm Metastasis
;
Neoplasm, Residual
;
Obstetrics
;
Ovarian Neoplasms*
;
P-Glycoprotein
;
Plasminogen
;
Plasminogen Activator Inhibitor 1
;
Prognosis
;
Proportional Hazards Models
;
Survival Rate
7.Clinico-Pathologic Study on Borderline Epithelial Tumors of the Ovary.
Sam Hyun CHO ; Seung Ryong KIM ; Hyang MOON ; Jai Auk LEE ; Youn Yeoung HWANG ; Young Jin MOON ; Dong Ik HAN ; Joong Sik SHIN ; Kyung Tal KIM
Korean Journal of Gynecologic Oncology and Colposcopy 1999;10(2):115-121
Twenty six cases of borderline ovarian tumor(BOT) were treated between Jan. 1985 and Dec. 1997 at the Department of Obstetrics and Gynecology, Hanyang University. The clinical records were reviewed for all patients including histopathology, clinical features, and follow-up. The frequency of BOT was 12%(26/214) of epithelial ovarian malignancies, and patients with these tumors tend to present at a younger age(36 yrs) than those with invasive carcinomas. In terms of histologic type, mucinous type(21/26: 81%) were more prevalent than serous tumor(5/21: 19%) in this study. The positive rate of CA 125 was 20% in serous, and the positive rate of CA 19-9 was 24% in mucinous tumor. The size of mucinous was larger than that of serous tumors(17.1 cm vs 9,3 cm). Almost all of these tumor categorized as early stage(stage I: 96%), however, only one patient with serous tumor had advanced stage of disease(stage III: 4%), Therefore BOT tend to be diagnosed as earlier than invasive carcinoma. About 2/3 of patients were treated as conservative surgery(unilateral salpingooophorectomy or enuclation). Postoperative adjuvant chemotherapy was not given about half of cases(13/26). Median follow-up was 43 months and recurrent case was found only one in serous tumor, All patients in this study are still alive and free of disease except one, 5-year survival rate was 100%. But large number of study and long-term follow-up are needed to make a decision to treat and manage of BOT.
Chemotherapy, Adjuvant
;
Female
;
Follow-Up Studies
;
Gynecology
;
Humans
;
Mucins
;
Obstetrics
;
Ovary*
;
Survival Rate
10.A Case of Malignant Mesothelioma of the Uterus.
Ki Young RYU ; Joong Sik SHIN ; Sam Hyun CHO ; Seung Ryong KIM ; Jung Bae YOO ; Kyung Tai KIM ; Youn Yeoung HWANG ; Seok Hoon JEON ; Jung Dal LEE ; Min Chul LEE
Journal of the Korean Cancer Association 1997;29(2):362-362
Malignant mesothelioma of the serosal surface of the uterus body is very rare and almost invariably malignant. Their diagnosis is made postoperatively in most instances.Various treatments have been described for malignant mesothelioma but effective method is still not known. A case of malignant mesothelioma of the uterus body with post-surgical pelvic persistence is presented. The diagnosis of carcinomatous mesothelioma was made postoperatively by pathologic examination and immunohistochemical reaction of the tumor cells.
Diagnosis
;
Mesothelioma*
;
Uterus*